This inventor holds 22 USPTO granted patents and 2 published patent applications, plus 9 CIPO patents and 7 EPO patents, primarily in Metabolic Modulation. Top assignees: Chugai Seiyaku Kabushiki Kaisha, University of Alberta, The Governors of the Univerity of Alberta. Active years: 2003-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Alberta, CA (2003)
- Edmonton, CA (2004 - 2012)
Company Filing History:
13 out of 991 
8 out of 455 
1 out of 2 Years Active: 2003-2012
Areas of Expertise:
Title: The Innovative Contributions of Gary David Lopaschuk
Introduction
Gary David Lopaschuk is a prominent inventor based in Edmonton, Canada, known for his significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of 22 patents, Lopaschuk has focused on innovations that enhance glucose utilization and metabolic modulation, showcasing his commitment to improving healthcare and treatment options.
Latest Patents
Among his most recent patents, Lopaschuk has developed "Compounds that stimulate glucose utilization and methods of use." This invention provides novel compounds that enhance glucose oxidation rates in myocardial cells, an essential process for heart health. It also includes pharmaceutical compositions designed to promote glucose oxidation and methods for treating myocardial ischemia.
Another significant patent is for "Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators." This invention features novel compounds and their prodrugs aimed at treating various metabolic diseases. By inhibiting the enzyme malonyl-coenzyme A decarboxylase, these compounds have potential applications in managing cardiovascular diseases, diabetes, acidosis, cancers, and obesity.
Career Highlights
Gary David Lopaschuk has a distinguished career that includes collaborations with leading institutions and companies. Notably, he has worked with Chugai Seiyaku Kabushiki Kaisha, a major player in pharmaceutical development, and The Governors of the University of Alberta, where he has engaged in research that ignited innovation in the medical field.
Collaborations
Lopaschuk has collaborated with esteemed colleagues such as Jason Roland Dyck and Jie Fei Cheng. These partnerships contribute to the synergy of research and advancement in pharmaceutical sciences, enabling Lopaschuk's inventions to reach their full potential in application and marketability.
Conclusion
In conclusion, Gary David Lopaschuk's work exemplifies the spirit of innovation in the field of pharmaceuticals. His inventions not only add to the scientific community's understanding of glucose metabolism but also pave the way for new treatment methods for chronic diseases. With a robust patent portfolio and continued collaboration with industry leaders, Lopaschuk remains a significant figure in the advancement of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile